Arcturus Therapeutics Holdings Inc

NASDAQ:ARCT

13.78

+0.16 (+1.18%)

3:11:19 PM EDT: $13.77 -0.01 (-0.07%)

Market Cap (Intraday)	378.13M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$19.61 Million
Adjusted EPS	-$0.89

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Arcturus Therapeutics Holdings Inc Stock, NASDAQ:ARCT

10628 Science Center Drive, Suite 250, San Diego, California 92121

United States of America

Phone: +1.858.900.2660

Number of Employees: 176

http://www.arcturusrx.com

Description

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.